ResultsIQ

ResultsIQ › Latest results › Colgate Palmolive (India) Limited

Colgate Palmolive (India) Limited investor meet summary

NSE: COLPAL · BSE: 500830

Investor meet of 17 Aug 2026, summarised by AI from the filing.

Colgate-Palmolive India reported Q1 FY27 sales of ₹1591 cr, up 12%, and guided growth ahead of profitability with an upward bias on advertising.

Key takeaways

  1. Q1 sales ₹1591 cr, 12% growth; first six months of the calendar year 10.5% ahead of oral care peers.
  2. Guidance Growth ahead of profitability; advertising has an upward bias and EBITDA percentage may be impacted.
  3. Driver Premiumisation and e-commerce are growth, margin, premiumisation and share accretive.
  4. Risk Competitive intensity remains high and competitors can copy initiatives.

Original filing on BSE

Colgate Palmolive (India) Limited Q1 FY27 results

As filed: Revenue ₹1,603 cr (+12% year on year), EBITDA ₹483 cr (+7% year on year), PAT ₹343 cr (+7% year on year), EBITDA margin 30.1% (−147 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,595 cr (+9% year on year), EBITDA ₹510 cr (+2% year on year), PAT ₹353 cr (0% year on year), EBITDA margin 31.9% (−209 bps). Score 53 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 209 bps year on year. Share price after the results: −7.4% in 28 days (Nifty 500: +2.2%).
  • Q3 FY26: Revenue ₹1,486 cr (+2% year on year), EBITDA ₹442 cr (−3% year on year), PAT ₹324 cr (0% year on year), EBITDA margin 29.7% (−138 bps). Score 39 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 138 bps year on year. Share price after the results: +6.7% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹1,520 cr (−6% year on year), EBITDA ₹465 cr (−6% year on year), PAT ₹328 cr (−17% year on year), EBITDA margin 30.6% (−11 bps). Score 24 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 11 bps year on year. Share price after the results: −4.6% in 29 days (Nifty 500: +0.1%).
  • Q1 FY26: Revenue ₹1,434 cr (−4% year on year), EBITDA ₹453 cr (−11% year on year), PAT ₹321 cr (−12% year on year), EBITDA margin 31.6% (−241 bps). Score 17 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 241 bps year on year. Profit fell 10% from last quarter. Share price after the results: −1.7% in 30 days (Nifty 500: −1.0%).
  • Q4 FY25: Revenue ₹1,463 cr (−2% year on year), EBITDA ₹498 cr (−6% year on year), PAT ₹355 cr (−7% year on year), EBITDA margin 34.0% (−160 bps). Score 16 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 160 bps year on year. Share price after the results: −9.7% in 30 days (Nifty 500: +1.4%).
  • Q3 FY25: Revenue ₹1,462 cr (+5% year on year), EBITDA ₹455 cr (−3% year on year), PAT ₹323 cr (−2% year on year), EBITDA margin 31.1% (−240 bps). Score 17 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 240 bps year on year. Revenue fell 10% from last quarter. Profit rose ₹-7.0 cr on a year ago, against ₹87.0 cr the year before.
  • Q2 FY25: Revenue ₹1,619 cr (+10% year on year), EBITDA ₹497 cr (+3% year on year), PAT ₹395 cr (+16% year on year), EBITDA margin 30.7% (−207 bps). Score 43 of 100, In line with trend. EBITDA margin fell 207 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Colgate Palmolive (India) Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.